论文信息 - Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial - 字舞流文

Docetaxel with or without Ramucirumab after Platinum-Based Chemotherapy and Checkpoint Inhibitors in Advanced Urothelial Carcinoma: A Pre-Specified Subgroup Analysis from the Phase 3 RANGE Trial

T. Powles | D. Petrylak | Chia‐Chi Lin | A. Necchi | A. Drakaki | U. Vaishampayan | M. V. D. Heijden | D. Castellano | S. Chowdhury | G. Gakis | A. Zimmermann | S. Bracarda | K. Chi | K. Bell-McGuinn | Jae-Lyun Lee | L. Geczi | D. Keizman | A. Flechon | Conor J. Kirby